Detalles de la búsqueda
1.
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
Am J Hematol;
99(4): 774-779, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38343062
2.
A mAb to SIRPα downregulates the priming of naive CD4 + T cell in Primary immune thrombocytopenia.
Cell Immunol;
391-392: 104757, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660478
3.
Patients with von Willebrand disease in China: Results of an online survey.
Haemophilia;
29(1): 230-239, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251718
4.
Clinical features and treatment effect of HIV-associated immune thrombocytopenia-single center Ten-Years data summary.
Platelets;
34(1): 2200836, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37114424
5.
Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
Platelets;
34(1): 2271568, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941414
6.
Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.
Haemophilia;
28(6): e199-e208, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802040
7.
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.
Am J Hematol;
97(12): 1510-1519, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054786
8.
SIRT1 single-nucleotide polymorphisms are associated with corticosteroid sensitivity in primary immune thrombocytopenia patients.
Ann Hematol;
100(10): 2453-2462, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34269838
9.
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.
Platelets;
32(5): 633-641, 2021 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614630
10.
CD70-silenced dendritic cells induce immune tolerance in immune thrombocytopenia patients.
Br J Haematol;
191(3): 466-475, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32419211
11.
Successful hip arthroplasty in a patient with combined deficiency of factor V and factor FVIII.
Haemophilia;
30(2): 558-560, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146236
12.
Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial.
Am J Hematol;
99(1): E22-E25, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37883528
13.
Inhibitory effect of circulating fibrocytes on injury repair in acute lung injury/acute respiratory distress syndrome mice model.
J Cell Biochem;
119(10): 7982-7990, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29323734
14.
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Am J Hematol;
98(7): E183-E186, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37128776
15.
Reduced MIR130A is involved in primary immune thrombocytopenia via targeting TGFB1 and IL18.
Br J Haematol;
166(5): 767-73, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24801815
16.
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study.
Lancet Reg Health West Pac;
47: 101096, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38808021
17.
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.
Clin Lymphoma Myeloma Leuk;
24(6): e257-e266, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38461040
18.
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Haematol;
2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38885672
19.
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
J Cancer Res Clin Oncol;
150(4): 189, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38605258
20.
Telomerase activity increased and telomere length shortened in peripheral blood cells from patients with immune thrombocytopenia.
J Clin Immunol;
33(3): 577-85, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23239407